RP-ZrO2 Stationary Phase as an Alternative to Separate of Doxazosin Impurities

Degradation products and related compounds occurring in drugs as impurities have often very similar properties as the parent substance. Therefore new analytical separation methods which show appropriate selectivity are required. Apart from improvements on silica-based reversed phases the attention has also been focused on other materials such as modified inorganic supports. In this study a polystyrene-coated zirconia was examined as an alternative in analysis of parent drug (doxazosin) and its impurities. Doxazosin and its five pharmacopoeial impurities were separated within 16 min. The suitability of the developed method was verified and confirmed by means of linearity, precision, inter-day precision, robustness and determination of LOD as well as LOQ. The results proved the potential of zirconia-based stationary phases to be useful alternatives in the field of drug analysis.